A critique and systematic review of the clinical utility of hepatitis B core-related antigen
- 28 December 2022
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 78 (4) , 731-741
Abstract
No abstract availableKeywords
Funding Information
- National Medical Research Council (NMRC/CIRG/1351/2013, NMRC/CIRG/1479/2017, NMRC/CSA-SI/0016/2017)
This publication has 91 references indexed in Scilit:
- New insight in the pathobiology of hepatitis B virus infectionGut, 2012
- HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapyLiver International, 2010
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence # †Hepatology, 2009
- Correlation between serum hepatitis B virus core‐related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patientsJournal of Medical Virology, 2008
- Hepatitis B Virus Core-Related Antigens as Markers for Monitoring Chronic Hepatitis B InfectionJournal of Clinical Microbiology, 2007
- Low serum level of hepatitis B core‐related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapyHepatology Research, 2007
- Hepatitis B virus core and core‐related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infectionJournal of Gastroenterology and Hepatology, 2005
- Hepatitis B Virus DNA-negative Dane Particles Lack Core Protein but Contain a 22-kDa Precore Protein without C-terminal Arginine-rich DomainJournal of Biological Chemistry, 2005
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001